UPDATE: Boenning & Scattergood Downgrades Regeneron Pharma (REGN) to Neutral
Tweet Send to a Friend
Boenning & Scattergood downgraded shares of Regeneron Pharma (NASDAQ: REGN) to a Neutral rating from its previous rating of Outperform.
This article: 208 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 208 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
